Vascular smooth muscle proliferation: Synergistic interaction between serotonin and low density lipoproteins

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1644-1651

  Koba, Shinji ^a   Pakala, Rajbabu ^b   Watanabe, Takuya ^a   Katagiri, Takashi ^a   Benedict, Claude R ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYINOSINIC ACID; SERGOLEXOLE MALEATE; SEROTONIN ANTAGONIST;

ARTICLE; CELL PROLIFERATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN MODIFICATION; RABBIT; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL DIVISION; LIPOPROTEINS, LDL; LYSERGIC ACID; MITOGENS; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; RABBITS; SEROTONIN; SEROTONIN ANTAGONISTS; VIRULENCE FACTORS, BORDETELLA;

EID: 0033231192     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00349-6     Document Type: Article

References (60)

1. Schwartz S.M., Reidy M.A., O'Brien E.R.M. Assessment of factors important in atherosclerotic occlusion and restenosis. Thrombosis and Haemost. 74:1995;541-551.
2. Campbell J.H., Campbell G.R. The role of smooth muscle cells in arteriosclerosis [Current opinion]. Lipidology. 5:1994;323-330.
3. Ross R., Glomset J.A. Atherosclerosis and the arterial smooth muscle cell. Science. 180:1973;1332-1339.
4. Fischer-Dzoga K., Fraser R., Wissler R.W. Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipemic serum and lymph. Exp Mol Pathol. 24:1976;346-359.
5. Fischer-Dzoga K., Wissler R.W. Stimulation of proliferation in stationary primary cultures of monkey aortic smooth muscle cells. II. Effect of varying concentrations of hyperlipemic serum and low density lipoproteins of varying dietary fat origins. Atherosclerosis. 24:1976;515-525.
6. Fless G.M., Kirvhausen T., Fischer-Dzoga K., et al. Serum low density lipoproteins with mitogenic effect on cultured aortic smooth muscle cells. Atherosclerosis. 41:1982;171-183.
7. Hessler J.R., Robertson A.L. Jr, Chisolem G.M. III. LDL induced cytotoxicity and its inhibition by HDL in human vascular smooth and endothelial cell in culture. Atherosclerosis. 32:1979;213-229.
8. Bjorkerud S., Bjorkerud B. Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro. Arterioscler Thromb. 14:1994;288-298.
9. Libby P., Mioa P., Ordovas J.M., Schaefer E.J. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol. 124:1985;1-8.
10. Chen J.K., Hoshi H., McClure D.B., McKeehan W.L. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J Cell Physiol. 129:1986;207-214.
11. Ikeda U., Oguchi A., Okada K., et al. Involvement of LDL receptor in the proliferation of vascular smooth muscle cells. Atherosclerosis. 110:1994;87-94.
12. Bjorkerud B., Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol. 16:1996;416-424.
13. Auge N., Pieraggi M.T., Thiers J.C., et al. Proliferation and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J. 309:1995;1015-1020.
14. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis effects on smooth muscle cell proliferation . Mol Cell Biochem. 111:1992;143-147.
15. Camejo G., Fager G., Rosengren B., et al. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 268:1993;14131-14137.
16. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 13:1992;341-390.
17. Wiztum J. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
18. Witztum J., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
19. Auge N., Anderieu N., Negre-Salvayre A., et al. The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem. 271:1996;19251-19255.
20. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis basic mechanisms: oxidation, inflammation, and genetics . Circulation. 91:1995;2488-2496.
21. Maier J.A.M., Barenghi L., Bradamante S., Pagani F. Induction of human endothelial cell growth by mildly oxidized low density lipoprotein. Atherosclerosis. 123:1996;115-121.
22. Aviram M. LDL-Platelet interaction under oxidative stress induces macrophage foam cell formation. Thromb Haemost. 74:1995;560-564.
23. Fetkovaska N. Platelet activation by low density lipoprotein and serotonin effects of calcium antagonist . J Cardiovasc Pharmacol. 19:(Suppl 3):1992;S25-S28.
24. Shimokawa H., Vanhoutte P.M. Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium. J Am Coll Cardiol. 17:1991;1197-1202.
25. Malyszko J., Urano T., Knofler R., et al. Correlations between platelet aggregation, fibrinolysis, peripheral and central serotonergic measures in subhuman primates. Atherosclerosis. 110:1994;63-68.
26. Pakala R., Willerson J.T., Benedict C.R. Mitogenic effect of serotonin on vascular endothelial cells. Circulation. 90:1994;1919-1926.
27. Crowley S.T., Dempsey E.C., Horwitz K.B., Horwitz L.D. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate . Circulation. 90:1994;1908-1918.
28. Pakala R., Willerson J.T., Benedict C.R. Effects of serotonin, thromboxane A2 and the specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation. 96:1997;2280-2286.
29. Sparrow C.P., Partthasarathy S., Steinberg D. Macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem. 264:1989;2599-2604.
30. Fetkovaska N., Fedelesova V., Dzuarik R. Low density lipoprotein amplifies the platelet response to serotonin in human plasma. J Hypertens. 7:(Suppl 6):1987;S164-S165.
31. Zhao B., Dierichs R., Harrach-Ruprecht B., Winterhorff H. Oxidized LDL induces serotonin release from blood platelets. Am J Hematol. 48:1995;285-287.
32. Andrews H.E., Aitkin J.W., Hassall D.G., et al. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem J. 242:1987;559-564.
33. 2. Arterioscler Thromb Vasc Biol. 15:1995;1131-1138.
34. Ferrei L.F. Fraction of plasma lipoprotein evaluation of preparative methods . Story J.A., Laboratory and Research Methods in Biology and Medicine. 1984;133-156 Alan R. Liss, New York.
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
36. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 30:1978;302-310.
37. Sambrano G.R., Parthasarathy S., Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci USA. 91:1994;3265-3269.
38. Stiko-Rahm A., Hultgardh-Nilsson A., Regnstrom J., et al. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Throm. 12:1992;1099-1109.
39. Takahashi A., Taniguchi T., Fujioka Y., et al. Effects of lipoprotein (a) and low density lipoprotein on growth of mitogen-stimulated human umbilical endothelial cells. Atherosclerosis. 120:1996;93-99.
40. Schreier L., Pagiero F., Sanguinetti S., Wikinski R. Influence of the medium on the assessment of LDL resistance to oxidation lag time in phosphate buffered saline is longer than in sodium chloride solution . Atherosclerosis. 129:1997;127-128.
41. Berliner J.A., Haberland M.E. The role of oxidized low-density lipoprotein in atherogenesis [Current opinion]. Lipidology. 4:1993;373-381.
42. Stiko A., Regnestrom J., Shah P.K., Cercek B., Nilsson J. Active oxygen species and Lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler Thromb Vasc Biol. 16:1996;194-200.
43. Pero R.W., Anderson M.W., Doyle G.A., et al. Oxidative stress induces DNA damage and inhibits the repair of DNA lesions induced by N-acetoxy-2-acetylaminofluorene in human peripheral mononuclear leukocytes. Cancer Res. 50:1990;4619-4625.
44. Cattley R.C., Oliver T.S., Butterworth B.E., Popp J.A. Failure of the peroxisome proliferator WY-14643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment. Carcinogenesis. 9:1988;1179-1183.
45. Rao G.N., Bradford C.B. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circulation. 70:1992;593-599.
46. Shibanuma M., Kuroki T., Nose K. Superoxide as a signal for increase in intracellular pH. J Cell Physiol. 136:1988;379-383.
47. Crawford D., Zbinden I., Amstad P., Cerutti P. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene. 3:1988;27-32.
48. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells AP-1 as secondary factor antioxidant-responsive factor . Embo J. 12:1993;2005-2015.
49. Rao G.N., Lassegue B., Griendling K.K., Alexander R.W. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells role of arachiodonic acid . Oncogene. 8:1993;2759-2764.
50. Shibanuma M., Kuroki T., Nose K. Induction of DNA replication and expression of proto-oncogene c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene. 3:1988;17-21.
51. Yamakawa T., Satoru E., Yamakawa Y., et al. Lysophosphatidylcholine stimulates MAP kinases activity in rat vascular smooth muscles cells. Hypertension. 31:1998;248-253.
52. 1-protein. Nature. 335:1988;254-256.
53. Derijard B., Hibi M., Wu I.H., et al. JNK1 a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain . Cell. 76:1994;1025-1037.
54. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1992;2135-2148.
55. Kyriakis J.M., Benerjee P., Nikolakaki E., et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
56. Rao G.N., Glasgow W.C., Eling T.E., Rung M.S. Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced protein (AP-1) activity. J Biol Chem. 271:1996;27760-27764.
57. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
58. Abe J., Kusuhara M., Ulevitch R.J., Berck B.C., Lee J.D. Big mitogen-activated protein kinase 1(BMK1) is a redox-sensitive kinase. J Biol Chem. 271:1996;16586-16590.
59. Kusuhara M., Chait A., Cader A., Berck B.C. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 17:1997;141-148.
60. Seewald S., Nickenig G., Ko Y., et al. Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells. Cardiovasc Res. 36:1997;92-100.